Overview
- Editors:
-
-
Waun Ki Hong
-
M. D. Anderson Cancer Center, The University of Texas, Houston, USA
-
Randal S. Weber
-
M. D. Anderson Cancer Center, The University of Texas, Houston, USA
Access this book
Other ways to access
Table of contents (15 chapters)
-
Front Matter
Pages i-xiii
-
-
- Dong M. Shin, Michael A. Tainsky
Pages 17-42
-
-
-
- Scott M. Lippman, Gary L. Clayman, Martin H. Huber, Steven E. Benner, Waun Ki Hong
Pages 89-115
-
- Douglas D. Boyd, Garth L. Nicolson
Pages 117-130
-
- Ralph R. Weichselbaum, Michael A. Beckett, Everett E. Vokes, David G. Brachman, Daniel Haraf, Dennis Hallahan et al.
Pages 131-140
-
- Jack L. Gluckman, Robert P. Zitsch
Pages 141-157
-
- Jack L. Gluckman, Louis G. Portugal
Pages 159-171
-
- Daniel J. Haraf, Ralph R. Weichselbaum, Everett E. Vokes
Pages 173-198
-
- Charles R. Dibb, Susan Urba, Gregory T. Wolf
Pages 199-219
-
- David L. Callender, Randal S. Weber
Pages 221-241
-
- Harlan A. Pinto, Charlotte Jacobs
Pages 243-262
-
- Arlene A. Forastiere, Susan G. Urba
Pages 263-281
-
-
Back Matter
Pages 293-304
About this book
Throughout the world, head and neck cancer is a major threat to public health and a significant challenge to both clinicians and basic scientists. Despite extensive efforts in primary prevention, screening, early detection, and therapy, long-term survival rates have not improved substantially in the last three decades. This book covers a wide range of exciting new findings in both clinical and basic sciences as they are relevant to head and neck cancer. These findings have recently enhanced our understanding of head and neck carcinogenesis at the genetic and molecular levels, offering the promise of improved preventive and therapeutic strategies. This book will also present information on the important clinical advances that have been made in chemoprevention, organ preservation, and the simultaneous use of chemo therapy and radiotherapy. The first part provides an overview of the etiology and biology of head and neck cancer, including an examination of human papillomaviruses in both benign and malignant lesions. This section also discusses the carcinogenic process at the genetic and molecular levels, as well as aberrant squamous differentiation; increased understanding of these areas has great potential to translate into new strategies for cancer prevention. The second part describes recent advances in developing a risk model for head and neck cancer, as well as the application of genetic susceptibility data in chemoprevention. This section also includes overviews of the status of chemoprevention trials and of the process of invasion and metastasis in head and neck cancer.
